Dr. Shen joined Vivo Capital in 2016 as a Venture Partner. She is an international pharmaceutical executive with more than 40 years of experience in the industry. Dr. Shen was the President and CEO, Board Member, and co-founder of ScinoPharm Taiwan, Ltd, a publicly listed leading process R&D and API manufacturing service provider to the global pharmaceutical industry.
Prior to establishing ScinoPharm in 1997, Dr. Shen was previously Corporate Vice President of Pharmaceutical Operations and Technology for Syntex from 1981, where she served for 14 years responsible for worldwide pharmaceutical manufacturing, operations, and technology transfer. Before that, she worked at Monsanto for 8 years in various technical and management positions in the synthetic fibers and semiconductor materials divisions.
Dr. Shen is a former board member of the U.S. Pharmaceutical Manufacturer Association (PhRMA), where she chaired the Production Group. She currently serves on a number of boards including the Development Center for Biotechnology, Taiwan Bio Industry Organization, China Chemical Society, and Taiwan Pharmaceutical Manufacturing Association (TPMA) where she chairs the Active Pharmaceutical Ingredients Committee.
Dr. Shen holds a Ph.D. in Chemistry from Lehigh University, an M.S. in Chemistry from University of Iowa and a B.S. of Chemical Engineering from National Taiwan University. Dr. Shen is the recipient of the “Women in Industry” award from the YWCA in California.